Acorah Software Products - Accounts Production 16.1.300 false true 30 September 2023 1 October 2022 false true No description of principal activity 1 October 2023 30 September 2024 30 September 2024 10967591 Dr Monjour Ahmed iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10967591 2023-09-30 10967591 2024-09-30 10967591 2023-10-01 2024-09-30 10967591 frs-bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 10967591 frs-bus:FilletedAccounts 2023-10-01 2024-09-30 10967591 frs-bus:Micro-entities 2023-10-01 2024-09-30 10967591 frs-bus:AuditExempt-NoAccountantsReport 2023-10-01 2024-09-30 10967591 frs-bus:Director1 2023-10-01 2024-09-30 10967591 2022-09-30 10967591 2023-09-30 10967591 2022-10-01 2023-09-30
Registered number: 10967591
Remedium Investments Ltd
Financial Statements
For The Year Ended 30 September 2024
Balance Sheet
Registered number: 10967591
2024 2023
£ £
Fixed assets 100 100
Current assets 25,356 8,089
NET CURRENT ASSETS 25,356 8,089
TOTAL ASSETS LESS CURRENT LIABILITIES 25,456 8,189
Accruals and deferred income (412 ) (733 )
NET ASSETS 25,044 7,456
CAPITAL AND RESERVES 25,044 7,456

Notes

1. General Information
Remedium Investments Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 10967591 . The registered office is 25 Ellenhall Close, Luton, LU3 1XH.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2023: NIL)
- -
For the year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Monjour Ahmed
Director
6 March 2025